Login / Signup

Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.

Antonio CristaudoDario GraceffaF PimpinelliF SperatiG SpoletiniC BonifatiR PelliniV LoraM PontoneO Di BellaD BraccoA Morrone
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Keyphrases
  • sars cov
  • rheumatoid arthritis
  • respiratory syndrome coronavirus
  • atopic dermatitis
  • drug induced